Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

408

HTML

4274

Figures (1-5)

222

Tables (1-3)

169

Sum=5073

Jun 21, 2012 (publication date) through Oct 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jun 21, 2012; 18(23): 2938-2947
Published online Jun 21, 2012. doi: 10.3748/wjg.v18.i23.2938

Table 1 Clinical and laboratory characteristics of the 60 hepatocellular carcinoma patients

Items	Results
Age (yr) median (range)	53.5 (17-77)
Gender (male/female)	51/9
Virus (HBV/HCV)	48/4
TNM stage (I/II/III/IV)	19/24/17/0
AFP (μg/L), median (range)	350 (1.8-127 278)
Blood neutrophil (%)	62.29 ± 10.96
Blood monocyte (%)	7.21 ± 1.69
Hemoglobin concentration (g/L)	124.47 ± 17.04

TNM: Tumor-node-metastasis; HBV: Hepatitis B virus; HCV: Hepatitis C virus; AFP: α-fetoprotein.

Citation: Yang J, Zhang JX, Wang H, Wang GL, Hu QG, Zheng QC. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling. World J Gastroenterol 2012; 18(23): 2938-2947
URL: https://www.wjgnet.com/1007-9327/full/v18/i23/2938.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i23.2938